Prevail Therapeutics

Lilly's Prevail walks away from gene editing collab with Precision
Fierce Biotech
Wed, 04/17/24 - 11:11 am
Eli Lilly
Prevail Therapeutics
gene editing
Precision Biosciences
Scribe's CRISPR tech Prevails in new $1.5B biobucks deal with Lilly unit
Fierce Biotech
Tue, 05/16/23 - 12:01 pm
Scribe Therapeutics
Eli Lilly
CRISPR
Prevail Therapeutics
gene therapy
biobucks
Jennifer Doudna
Lilly's Prevail, Capsida partner to develop gene therapies for nervous system diseases
BioPharma Dive
Wed, 01/4/23 - 05:32 pm
Eli Lilly
gene therapy
Capsida
CNS disorders
Prevail Therapeutics
Biopharma throws grease on the deal wheels
EP Vantage
Wed, 07/21/21 - 10:52 am
M&A
Alexion
Achillion
Eli Lilly
Prevail Therapeutics
Eli Lilly to buy New York drugmaker for up to $1B
Beckers Hospital Review
Thu, 12/31/20 - 11:59 am
Eli Lilly
Prevail Therapeutics
M&A
neurodegenerative disease
Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn
Biopharma Reporter
Tue, 12/15/20 - 10:57 am
Eli Lilly
Prevail Therapeutics
M&A
FDA Awards Orphan Drug Designation to Prevail's Gene Therapy for Gaucher Disease
BioSpace
Fri, 02/14/20 - 10:47 am
FDA
Prevail Therapeutics
gene therapy
Gaucher disease
Prevail and Lonza Deepen Partnership with New Collaboration
BioSpace
Tue, 10/8/19 - 09:03 pm
Prevail Therapeutics
Lonza
baculovirus/Sf9 expression
gene therapy
neurodegenerative disease
Alector, Prevail trade blows over alleged misuse of confidential information
Fierce Biotech
Fri, 08/16/19 - 10:12 am
Alector
Prevail Therapeutics
trade secrets
FDA Grants Fast Track Designation For Prevail's Parkinson's Treatment
Yahoo/Benzinga
Tue, 07/9/19 - 08:42 am
Prevail Therapeutics
FDA
PR001
fast track
Back to business for biotech flotations
EP Vantage
Wed, 07/3/19 - 09:48 am
IPOs
BridgeBio
Turning Point Therapeutics
Stoke Therapeutics
Prevail Therapeutics
Atreca
NGM Biopharmaceuticals
Akero Therapeutics
Milestone Pharmaceuticals
Morphic Therapeutics
Karuna
Four More Through the IPO Door as Life Science Firms Raise $465M
Xconomy
Thu, 06/20/19 - 11:48 am
IPOs
Personalis
Akero Therapeutics
Prevail Therapeutics
Atreca
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/16/19 - 05:41 pm
FDA
Merck
Arqule
Affimed
BeiGene
Epizyme
MorphoSys
Theravance
Allena Pharma
Akero Therapeutics
Atreca
Dermavant Sciences
Personalis
Prevail Therapeutics
Stoke Therapeutics
IPOs
New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero
BioCentury
Mon, 05/27/19 - 11:42 pm
IPOs
BridgeBio
Dermavant
Prevail Therapeutics
Atreca
Akero Therapeutics
Gene therapy company Prevail raises $50M series B
BioCentury
Wed, 03/27/19 - 11:39 pm
Prevail Therapeutics
gene therapy
neurodegenerative disease
Prevail grabs $75M A round in the hunt for new gene therapies to stop the destruction caused by Parkinson’s
Endpoints
Thu, 03/8/18 - 10:28 am
Prevail Therapeutics
gene therapy
Parkinson's Disease